NEW YORK (GenomeWeb News) – Agilent Technologies said today that it plans to collaborate with the University of Queensland Centre for Clinical Research in Brisbane, Australia in an exome sequencing study of oral cancer patients.

The goal of the collaboration is to understand the genomic differences between young and older patients and between progressive and non-progressive lesions. Both young and older patients with oral squamous cell carcinoma as well as young and older patients with oral potentially malignant lesions will be studied.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.